TransMedics shareholders reject say-on-pay and stock incentive plan at 2022 annual meeting

TransMedics Group, Inc.

All eight director nominees elected; Waleed Hassanein received 17.9M for votes.
Say-on-pay advisory vote failed: 10.4M against vs 7.5M for.
Amended 2019 stock incentive plan not approved: 10.58M against vs 7.36M for.
Advisory vote on frequency approved 1 year with 17.9M votes.
Ratification of PwC as auditor passed with 20.0M for votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.